VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener
ScreenerThemesMarketEarningsCompareWatchlistInsider
CUPRCuprina Holdings (Cayman) Limited Class A Ordinary Shares
$4.37$12M
Research
Overview
Valuation
ValuationTargetsPrice
Financials
RevenueEarningsP/ERatiosDividend
Ownership
Holders
Tools
Total ReturnDCA Calculator
← Back to Screener
VCP ScannerFree US Stock Screener & Financial Analysis

Find stocks. Verify deeply. Act with conviction.

Data updated daily

Product

  • Screener
  • Themes
  • Valuation
  • Total Return
  • DCA Calculator
  • News
  • Earnings

Resources

  • Market Valuation
  • Compare
  • Insider Activity
  • Methodology
  • How It Works
  • Glossary
  • Learn

Get Ideas

Get weekly stock ideas — free

Follow VCP Scanner on XFollow VCP Scanner on LinkedIn
© 2026 VCP Scanner
AboutPrivacyTerms
Not financial advice. Do your own research.
ScreenerNewsCompareWatchlist

CUPR logoCuprina Holdings (Cayman) Limited Class A Ordinary Shares(CUPR)Earnings, Financials & Key Ratios

CUPR•NASDAQ
Price updated Jun 19, 2026
SectorHealthcareIndustryBiotechnologySub-IndustryCommercial Specialty Pharma
AboutCuprina Holdings (Cayman) Limited is a Singapore-based biomedical and biotechnology company dedicated to developing and commercializing innovative products for managing chronic wounds. The company manufactures and distributes medical-grade sterile blowfly larvae bio-dressing products under the MEDIFLY brand, used as a biological debridement tool for chronic wounds. Additionally, Cuprina operates in the health and beauty sectors, offering cosmeceutical products.Show more
  • Revenue$50K+3.3%
  • EBITDA-$5M-182.6%
  • Net Income-$5M-199.5%
  • EPS (Diluted)-1.84-220.8%
  • Gross Margin-1.29%+79.3%
  • EBITDA Margin-9081.41%-173.7%
  • Operating Margin-9154.62%-168.9%
  • Net Margin-9366.75%-190.0%
  • ROE-1569.05%

CUPR Key Insights

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) fundamental analysis — strengths, weaknesses & financial health based on data analysis

✓Strengths

  • ✓Company is almost debt free
  • ✓High quality earnings: Operating CF exceeds net income
  • ✓Share count reduced 5.9% through buybacks

✗Weaknesses

  • ✗Negative free cash flow
  • ✗Trading more than 30% below 52-week high
  • ✗Low asset turnover indicates capital-intensive operations

* These insights are generated automatically based on available financial data. Please conduct your own research before making investment decisions.

Get notified when CUPR posts new earnings or crosses analyst targets

Free. No account needed. Unsubscribe any time.

Free. Unsubscribe any time.

CUPR Price & Volume

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) stock price & volume — 10-year historical chart

Loading chart...

CUPR Growth Metrics

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) revenue, earnings & EPS growth — 3, 5 & 10-year CAGR

Revenue CAGR

10 Years-
5 Years-
3 Years-4.12%
TTM-

Profit CAGR

10 Years-
5 Years-
3 Years-
TTM-

EPS CAGR

10 Years-
5 Years-
3 Years-
TTM-

Return on Capital

10 Years-835.65%
5 Years-835.65%
3 Years-835.65%
Last Year-835.65%

CUPR Peer Comparison

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) competitors in Commercial Specialty Pharma — business model, growth, and fundamentals comparison

Select Columns
Stock Universe
Valuation
Growth
Profitability
Financial Health
Dividends & Buybacks
Price Performance
Technical
Fundamentals ($)
Sector-Specific
Institutional Holdings
CompanyMarket CapStock PriceP/E Ratio (TTM)Revenue Growth 1YNet MarginReturn on Equity (ROE)FCF YieldDebt / Equity
HROW logoHROWHarrow Health, Inc.Direct Competitor1.6B42.87-306.2136.41%-5.57%-33.92%4.84
PAHC logoPAHCPhibro Animal Health CorporationDirect Competitor1.29B31.8526.7627.37%6.29%30.81%2.67
ELAN logoELANElanco Animal Health IncorporatedProduct Competitor12.1B24.22-51.536.22%-4.95%-3.64%0.61
ZTS logoZTSZoetis Inc.Product Competitor33B78.7113.072.28%27.79%62.41%2.85
PCRX logoPCRXPacira BioSciences, Inc.Product Competitor878.35M22.33139.563.63%1.27%1.31%0.66
PRGO logoPRGOPerrigo Company plcProduct Competitor1.42B10.25-1.00-2.75%-43.5%-50.65%1.35
IDXX logoIDXXIDEXX Laboratories, Inc.Supply Chain44.64B562.0942.9710.42%24.63%70.87%0.67
CHWY logoCHWYChewy, Inc.Supply Chain7.54B18.2135.026.24%1.57%44.82%1.12

Compare CUPR vs Peers

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) vs competitors — business, growth, and fundamentals comparison against the closest industry rivals.

Closest Rival

vs HROW

Most directly comparable listed peer for CUPR.

Scale Benchmark

vs IDXX

Larger-name benchmark to compare CUPR against a more recognizable public peer.

Peer Set

Compare Top 5

vs HROW, PAHC, ELAN, ZTS

CUPR Income Statement

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) annual income statement — 10-year revenue, gross profit & net income history

10Y historyFree accessUpdated daily
MetricDec'21Dec'22Dec'23Dec'24Dec'25
Sales/Revenue
58.5K56.6K100.77K48.32K49.89K
Revenue Growth %
--3.26%78.05%-52.05%3.26%
Cost of Goods Sold
35.45K36.62K64.17K51.34K50.54K
COGS % of Revenue
60.59%64.7%63.68%106.26%101.29%
Gross Profit
23.06K▲ 0%
19.98K▼ 13.4%
36.6K▲ 83.2%
-3.02K▼ 108.3%
-645▲ 78.7%
Gross Margin %
39.41%35.3%36.32%-6.26%-1.29%
Gross Profit Growth %
--13.35%83.23%-108.26%78.67%
Operating Expenses
575.81K1.2M1.1M1.64M4.57M
OpEx % of Revenue
984.22%2112.7%1096.46%3398.59%9153.32%
Selling, General & Admin
248.19K830.36K833.45K1.27M4.39M
SG&A % of Revenue
424.23%1467.08%827.05%2626.72%8807.78%
Research & Development
279.79K292.88K167.73K241.36K226.88K
R&D % of Revenue
478.23%517.46%166.45%499.5%454.73%
Other Operating Expenses
47.83K72.53K103.75K131.62K-54.48K
Operating Income
-552.75K▲ 0%
-1.18M▼ 112.7%
-1.07M▲ 9.1%
-1.65M▼ 54.0%
-4.57M▼ 177.6%
Operating Margin %
-944.81%-2077.4%-1060.13%-3404.85%-9154.62%
Operating Income Growth %
--112.72%9.14%-54%-177.62%
EBITDA
-525.29K-1.15M-1.03M-1.6M-4.53M
EBITDA Margin %
-897.88%-2026.01%-1025.34%-3317.55%-9081.41%
EBITDA Growth %
--118.3%9.89%-55.15%-182.65%
D&A (Non-Cash Add-back)
27.46K29.09K35.06K42.19K36.52K
EBIT
-516.9K-1.09M-1.03M-1.47M-4.6M
Net Interest Income
-2.78K-2.02K-56.59K-37.21K11.84K
Interest Income
000026.56K
Interest Expense
2.78K2.02K56.59K37.21K14.72K
Other Income/Expense
33.07K88.62K-17.44K136.66K-105.84K
Pretax Income
-519.69K▲ 0%
-1.09M▼ 109.2%
-1.09M▲ 0.1%
-1.51M▼ 38.9%
-4.67M▼ 209.8%
Pretax Margin %
-888.29%-1920.83%-1077.44%-3122.05%-9366.75%
Income Tax
07.34K33.79K51.93K0
Effective Tax Rate %
0%-0.68%-3.11%-3.44%0%
Net Income
-519.69K▲ 0%
-1.09M▼ 110.6%
-1.12M▼ 2.3%
-1.56M▼ 39.4%
-4.67M▼ 199.5%
Net Margin %
-888.29%-1933.81%-1110.97%-3229.52%-9366.75%
Net Income Growth %
--110.61%-2.29%-39.39%-199.48%
Net Income (Continuing)
-519.69K-1.09M-1.12M-1.56M-4.67M
Discontinued Operations
00000
Minority Interest
00000
EPS (Diluted)
-0.20▲ 0%
-0.43▼ 110.2%
-0.41▲ 3.6%
-0.57▼ 39.2%
-1.84▼ 220.8%
EPS Growth %
--110.24%3.56%-39.22%-220.78%
EPS (Basic)
-0.20-0.43-0.41-0.57-1.84
Diluted Shares Outstanding
2.56M2.56M2.72M2.72M2.56M
Basic Shares Outstanding
2.56M2.56M2.72M2.72M2.56M
Dividend Payout Ratio
-----

CUPR Balance Sheet

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) balance sheet — assets, liabilities & shareholders' equity

MetricDec'21Dec'22Dec'23Dec'24Dec'25
Total Current Assets
808.19K1.27M1.44M1.66M7.33M
Cash & Short-Term Investments
767.29K564.58K35.26K116.47K3.12M
Cash Only
767.29K564.58K35.26K116.47K3.12M
Short-Term Investments
00000
Accounts Receivable
19.52K440.04K211.88K119.47K255.95K
Days Sales Outstanding
121.82.84K767.45902.471.87K
Inventory
06.5K7.67K1.73K0
Days Inventory Outstanding
-64.843.612.3-
Other Current Assets
14.49K157.9K1.04M1.27M3.67K
Total Non-Current Assets
144.86K166.97K150.65K89K1.17M
Property, Plant & Equipment
144.86K159.08K150.65K89K394.25K
Fixed Asset Turnover
0.40x0.36x0.67x0.54x0.13x
Goodwill
00000
Intangible Assets
00000
Long-Term Investments
07.89K000
Other Non-Current Assets
0000779.17K
Total Assets
953.05K▲ 0%
1.44M▲ 50.7%
1.59M▲ 10.4%
1.75M▲ 10.0%
8.5M▲ 387.4%
Asset Turnover
0.06x0.04x0.06x0.03x0.01x
Asset Growth %
-50.69%10.42%10.05%387.36%
Total Current Liabilities
1.51M3.09M4.43M6.04M3.12M
Accounts Payable
2200001.18K
Days Payables Outstanding
2.27---8.5
Short-Term Debt
19.46K19.95K20.85K55.25K38.73K
Deferred Revenue (Current)
00000
Other Current Liabilities
00000
Current Ratio
0.54x0.41x0.32x0.27x2.35x
Quick Ratio
0.54x0.41x0.32x0.27x2.35x
Cash Conversion Cycle
-----
Total Non-Current Liabilities
127.28K122.91K57.51K163.73K333.76K
Long-Term Debt
63.12K43.17K21.7K163.73K126.2K
Capital Lease Obligations
64.15K79.74K35.81K0207.56K
Deferred Tax Liabilities
00000
Other Non-Current Liabilities
00000
Total Liabilities
1.64M3.21M4.48M6.2M3.45M
Total Debt
170.03K183.63K121.82K254.79K482.72K
Net Debt
-597.26K-380.94K86.56K138.32K-2.63M
Debt / Equity
----0.10x
Debt / EBITDA
-----
Net Debt / EBITDA
-----
Interest Coverage
-185.74x-538.00x-18.19x-39.54x-312.10x
Total Equity
-683.52K▲ 0%
-1.78M▼ 160.2%
-2.9M▼ 62.9%
-4.46M▼ 53.9%
5.06M▲ 213.4%
Equity Growth %
--160.17%-62.92%-53.93%213.36%
Book Value per Share
-0.27-0.69-1.07-1.641.98
Total Shareholders' Equity
-683.52K-1.78M-2.9M-4.46M5.06M
Common Stock
24.2K24.2K24.2K24.2K28.61K
Retained Earnings
-786.45K-1.88M-3M-4.56M-9.23M
Treasury Stock
00000
Accumulated OCI
0-261309-1.59K348.54K
Minority Interest
00000

CUPR Cash Flow Statement

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) cash flow — operating, investing & free cash flow history

MetricDec'21Dec'22Dec'23Dec'24Dec'25
Cash from Operations
-221.86K-1.85M-1.54M-1.24M-9.13M
Operating CF Margin %
-379.22%-3268.03%-1530.94%-2557.85%-18306.71%
Operating CF Growth %
--733.71%16.59%19.89%-639%
Net Income
-519.69K-1.09M-1.12M-1.56M-4.67M
Depreciation & Amortization
27.46K29.09K35.06K42.19K36.52K
Stock-Based Compensation
00000
Deferred Taxes
00000
Other Non-Cash Items
4.58K22.98K64.79K54.01K204.73K
Working Capital Changes
265.79K-807.22K-523.07K228.36K-4.7M
Change in Receivables
-18.8K-38.25K-35.02K24.43K8.15K
Change in Inventory
0-6.5K-1.16K00
Change in Payables
-2.03K-22000-1.18K
Cash from Investing
-2.86K-31.28K-67.98K-21.88K-58.23K
Capital Expenditures
-2.86K-16.05K-67.98K-21.88K-58.23K
CapEx % of Revenue
4.89%28.36%67.46%45.29%116.71%
Acquisitions
0-15.23K000
Investments
-----
Other Investing
00000
Cash from Financing
991.39K1.68M1.08M1.34M12.23M
Debt Issued (Net)
82.58K-19.46K-20.57K176.43K-54.05K
Equity Issued (Net)
000017.61M
Dividends Paid
00000
Share Repurchases
00000
Other Financing
908.81K1.7M1.1M1.16M-5.32M
Net Change in Cash
766.67K▲ 0%
-202.72K▼ 126.4%
-529.31K▼ 161.1%
81.21K▲ 115.3%
3M▲ 3595.7%
Free Cash Flow
-224.72K▲ 0%
-1.87M▼ 730.2%
-1.61M▲ 13.7%
-1.26M▲ 21.9%
-9.19M▼ 630.8%
FCF Margin %
-384.11%-3296.39%-1598.4%-2603.14%-18423.41%
FCF Growth %
--730.24%13.67%21.91%-630.78%
FCF per Share
-0.09-0.73-0.59-0.46-3.59
FCF Conversion (FCF/Net Income)
0.43x1.69x1.38x0.79x1.95x
Interest Paid
2.78K2.02K72722170.58K
Taxes Paid
00000

CUPR Key Ratios

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) financial ratios — P/E, ROE, debt and 30+ core market and balance-sheet ratios

Metric20212022202320242025
Return on Equity (ROE)
-----1569.05%
Gross Margin
39.41%35.3%36.32%-6.26%-1.29%
Net Margin
-888.29%-1933.81%-1110.97%-3229.52%-9366.75%
Debt / Equity
----0.10x
Interest Coverage
-185.74x-538.00x-18.19x-39.54x-312.10x
FCF Conversion
0.43x1.69x1.38x0.79x1.95x
Revenue Growth
--3.26%78.05%-52.05%3.26%
Related:CUPR Dividend History·CUPR Revenue History·CUPR Price History·CUPR P/E History·CUPR Financial Ratios·CUPR Institutional Holders

CUPR Frequently Asked Questions

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) stock FAQ — growth, dividends, profitability & financials explained

Growth & Financials

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) reported $0.0M in revenue for fiscal year 2025. This represents a 15% decrease from $0.1M in 2021.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) grew revenue by 3.3% over the past year. Growth has been modest.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) reported a net loss of $4.7M for fiscal year 2025.

Dividend & Returns

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) has a return on equity (ROE) of -1569.1%. Negative ROE indicates the company is unprofitable.

Cuprina Holdings (Cayman) Limited Class A Ordinary Shares (CUPR) had negative free cash flow of $9.2M in fiscal year 2025, likely due to heavy capital investments.

What if you invested $1,000 in CUPR back in 2021?

Total return calculator · dividends reinvested · 5+ years of data

See returns →

How much would $100/month in CUPR be worth today?

Dollar cost averaging calculator · DCA vs lump sum

Calculate →